{
  "ticker": "JCS",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02977661",
  "id": "02977661",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250806",
  "time": "1707",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250806/pdf/06mlvs9nyldkch.pdf",
  "summary": "- **Material Change in Director's Holdings**:  \n  - **Net sales by Dr Philip Ewart**: Sold **739,426 ordinary shares** across multiple transactions (largest single sale: **400,000 shares** on 29/11/2024).  \n  - **Net acquisitions by related entities**:  \n    - Ewart Superannuation A/C acquired **1,090,154 ordinary shares** (largest single purchase: **400,000 shares** on 29/11/2024).  \n    - P Ewart Investments Pty Ltd acquired **901,083 ordinary shares** (largest single purchase: **169,621 shares** on 24/09/2024).  \n  - **Net result**: Combined entities increased holdings by **1,251,811 shares** (from **64.8M to 65.86M shares**).  \n\n**Key Takeaway**: Director-related entities are net buyers despite individual director sales, suggesting internal rebalancing. No immediate trading signal, but large transactions may indicate liquidity events or strategic positioning.  \n\n*Omitted: Minor transactions (<1,000 shares), exact dates, and non-material accounts.*",
  "usage": {
    "prompt_tokens": 1955,
    "completion_tokens": 239,
    "total_tokens": 2194,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-06T07:45:55.915428"
}